NHIA News
NHIA Comments on Proposed EIP LCD
September 5, 2025
NHIA submitted comments to the DME MAC medical directors regarding their proposed local coverage determination (LCD) for external infusion pumps (EIPs). DL33794 would expand Medicare Part B coverage for blinatumomab (Blimcyto®, Amgen) for certain indications. The association favors expanded access to therapy, but registered concerns about the fragmentation between the DME-infused drug benefit and the HIT services benefit and its lack of sufficient coverage for pharmacy services. NHIA also asked for clarification regarding provider’s ability to use non-proprietary EIPs to administer foscarbidopa/foslevodopa (Vyalev
, Abbvie) in the event of a supply chain issue.
Related Posts
NHIA Welcomes WeInfuse to the Future of Infusion Advisory Council
July 1, 2025
The National Home Infusion Association (NHIA) and WeInfuse are pleased to announce the addition of WeInfuse to NHIA’s Future of Infusion Advisory Council (FIAC).
NHIA Announces Finalists for 2025 Innovation Award
March 25, 2025
The National Home Infusion Association has announced the finalists for its 2025 Exhibitor Innovation Award. The award recognizes groundbreaking products or services that advance the home and alternate site infusion industry.
Pentec Health and Vital Care Infusion Services to Join NHIA Board of Directors
March 25, 2025
NHIA announces two new companies will join its 2024-2025 Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Joining the NHIA Board of Directors are Pentec Health, represented by Matthew Deans, CEO and Vital Care Infusion Services, represented by Logan Davis, Executive VP of Trade Relations and Strategy. In addition to the newly installed members, Upstate Home Care, Froedtert Health, and Amerita were elected to additional terms.
The post NHIA Comments on Proposed EIP LCD appeared first on National Home Infusion Association.